calcium channel blockers 1phrm-520-l.s.no-7th-e-01
TRANSCRIPT
![Page 1: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/1.jpg)
CALCIUM CHANNEL
BLOCKERS
1PHRM-520-L.S.No-7th-E-01
![Page 2: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/2.jpg)
Calcium Flow Pathways
2
![Page 3: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/3.jpg)
Ca+2 ION • Calcium ions are the principal intracellular
signaling ions (Release of stored Ca+2)
• Regulate excitation–contraction coupling secretion
• Activity of many enzymes
• Excitatory Neurotransmitter
• Ion channels, Hormone
• Transporters such as the sodium-calcium exchanger (NCX), also play important roles in [Ca2+] regulation. 3
![Page 4: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/4.jpg)
Types of Muscle TissueSkeletal
•Attach to and move skeleton•40% of body weight•Fibers = multinucleate cells (embryonic cells fuse)•Cells with obvious striations•Contractions are voluntary
Cardiac: only in the wall of the heart
•Cells are striated•Contractions are involuntary (not voluntary)
Smooth: walls of hollow organs•Lack striations•Contractions are involuntary (not voluntary) 4
![Page 5: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/5.jpg)
5
![Page 6: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/6.jpg)
Similarities…• Their cells are called fibers because
they are elongated
• Contraction depends on myofilaments
–Actin
–Myosin
• Plasma membrane is called sarcolemma
–Sarcos = flesh
–Lemma = sheath 6
![Page 7: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/7.jpg)
[Ca2+]i Three Best Studied Roles:
1. Contraction of Muscle 2. Secretion 3. Gating
7
![Page 8: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/8.jpg)
The Ion… Ca2+
8
![Page 9: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/9.jpg)
• The calcium that enters the cell during action potentials must be removed from the cell otherwise an accumulation of calcium would lead to cellular dysfunction.
• Calcium is removed from cells by two basic mechanisms.
• 1. An ATP-dependent Ca++ pump that actively removes calcium from the cell.
• 2. Sodium-calcium exchanger.
Sodium-Calcium Exchanger (NCX)
9
![Page 10: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/10.jpg)
When the cell is depolarized and has a positive membrane potential, the exchanger works in the opposite direction (i.e., Na+ leaves and Ca++ enters the cell).
10
![Page 11: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/11.jpg)
11
Drugs Acting on Calcium Channels
Calcium Channel Blockers
L-type Ca channel blocker
T-type Ca channel blocker•Verapamil
•Diltiazem
•Nifedipine
•Pimozid
•Mibefradil
•Succinimide Antiepliptic drugs
•Phenytoin
NPQR Ca channel blocker•Gabapentin
![Page 12: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/12.jpg)
Cardiac-Types of Ca+2 Channels: 2 types of Ca2+ channels:
– L- (low threshold type) – T-type (transient-type)
Transport Ca2+ into the cells
The L-type channel is found in all cardiac cell types and vascular smooth muscle.
The T-type channel is found: pacemaker, atrial, and Purkinje cells.
12
![Page 13: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/13.jpg)
Difference Between L/T Type
13
![Page 14: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/14.jpg)
14
![Page 15: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/15.jpg)
15
![Page 16: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/16.jpg)
Excitation-contraction (E-C) coupling
•It is the process depolarization of the muscle fiber membrane, elicited by a nerve action potential, triggers the release of Ca2+ from the sarcoplasmic reticulum (SR).
•resulting rise in intracellular Ca2+
•concentration activates the troponin complex,
•initiating the contraction of the muscle. 16
![Page 17: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/17.jpg)
Myofibrils
• Made of three types of filaments (or myofilaments):– Thick (myosin)– Thin (actin)– Elastic (titin)
______actin_____________myosintitin_____
17
![Page 18: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/18.jpg)
18
![Page 19: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/19.jpg)
Contraction
19
![Page 20: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/20.jpg)
Myosins belong to a large superfamily
Motor proteins that move along actin
filaments, by hydrolyzing ATP.
There are 20 classes of myosin
Distinguished on the basis of the sequence of amino acids in their ATP-hydrolyzing motor domains.
20
![Page 21: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/21.jpg)
Myosin II first studied for its role in muscle contraction, but it functions also in non-muscle cells.
Myosin II includes 2 heavy chains.The globular motor domain of each heavy
chain catalyzes ATP hydrolysis, and interacts with actin.
-helical coiled coil
heavy chain motor domains
Myosin II
light chains
21
![Page 22: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/22.jpg)
2 Light chains, designated essential & regulatory, wrap around the neck region of each myosin II heavy chain.
light chains may help to stiffen the neck.
Ca++- Calmodulin wrapped around its target peptide
PDB 1CDM
Myosin head & neck
PDB 2MYS
22
![Page 23: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/23.jpg)
• Each heavy chain continues into a tail domain in which heptad repeat sequences promote dimerization by interacting to form a rod-like -helical coiled coil.
23
![Page 24: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/24.jpg)
24
![Page 25: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/25.jpg)
Another Picture
25
![Page 26: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/26.jpg)
26
![Page 27: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/27.jpg)
27
![Page 28: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/28.jpg)
Special Functional Characteristics of Muscle
Contractility Only one action: to shorten Shortening generates pulling force
Excitability Nerve fibers cause electrical impulse to travel
Extensibility Stretch with contraction of an opposing muscle
Elasticity Recoils passively after being stretched
28
![Page 29: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/29.jpg)
Sliding Filament Model
__relaxed sarcomere__ _partly contracted_
fully contractedSarcomere shortens because actin pulled towards its middle by myosin cross bridges
Titin resists overstretching29
![Page 30: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/30.jpg)
CALCIUM CHANNEL• Calcium is stored in the sarcoplasmic
reticulum• When the impulse is initiated the T tubules
release free Ca++• This free Ca++ reacts with the troponin to
increase the number of cross bridges (actin + myocin)
• Just as increasing the number of persons pulling on a rope in a “tug of war” will increase the tension or the pull on the rope
• This increase in the number of active cross bridges will increase the strength of the cardiac contraction
30
![Page 31: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/31.jpg)
Animation: Myosin V walking along an actin filament.Based on electron microscopic images of myosin V fragments (part of the tail domain with 2 heads) attached to actin filaments in what is interpreted as different stages of the reaction cycle. (By M. L. Walker, S. A. Burgess, J. R. Sellers, F. Wang, J. A. Hammer, J. Trinick & P. J. Knight.)
processive movement of myosin V along F-actin
High resolution electron microscopy has detected conformations consistent with the hand-over-hand stepping mechanism.
31
![Page 32: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/32.jpg)
32
![Page 33: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/33.jpg)
33
![Page 34: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/34.jpg)
http://calcium.ion.ucl.ac.uk/calcium-channels.html http://www.sigmaaldrich.com
Structure of Ca+2 Channel• A combination of 5 subunits, α1, α2, β, γ, and δ, unite to form
the channel in its native state. • The β subunit increases channel expression ≈10-fold
and accelerates the activation and inactivation kinetics.
• The α1c subunit, Cav1.2, is the cardiac-specific subunit
34
![Page 35: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/35.jpg)
Ca+2 Channel α1c subunit• 4 homologous domains
• Each domain consists 6 membrane-spanning segments.
• The P-loop of each domain contributes a glutamate residue (E) to the pore structure. pore loop contributes to selectivity
• These residues (EEEE) are critical for calcium selectivity;
35
![Page 36: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/36.jpg)
Alpha-1 Subunit Structure
http://calcium.ion.ucl.ac.uk/calcium-channels.html
The α1c subunit, Cav1.2, is the cardiac-specific subunit
36
![Page 37: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/37.jpg)
Ribbon Structure of Alpha-1
http://calcium.ion.ucl.ac.uk/calcium-channels.html 37
![Page 38: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/38.jpg)
Structure/Function
• Positively charged lysine and arginine residues in the S4 transmembrane segment thought to form the voltage sensor
• The carboxyl terminus has multiple Ca2+ binding sites and Ca-calmodulin–dependent kinase activity.
38
![Page 39: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/39.jpg)
Two Primary Proteins• Involved in the initial events of E-
C coupling: –1. Dihydropyridine receptor (DHPR)
–2. Ryanodine receptor (RYR),
• are both Ca2+ channels.
• Skeletal and cardiac muscle have
• different isoforms of both the DHPR and RYR. 39
![Page 40: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/40.jpg)
DHPR in Skeletal Muscle
• It is an L-type Ca 2+ channel,
• is composed of four subunits:
• α1S(190–212 kDa),
• α2–
• β(52–58 kDa),
• γ (25 kDa).
• δ(125 kDa), 40
![Page 41: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/41.jpg)
DHPR in heart • The cardiac DHPR has three known
subunits:
• α1C (240 kDa)
• α2–δ(125 kDa)
• β(62 kDa).
• The γ-subunit has not yet been identified as a subunit of the cardiac channel.
41
![Page 42: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/42.jpg)
α1-Subunit of the DHPR
• α1-subunit of the DHPR forms the channel pore
• and contains the binding sites for channel-specific drugs
42
![Page 43: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/43.jpg)
Excitation-contraction (E-C) coupling:
•Depolarization of the muscle fiber membrane by a nerve action potential,
•triggers the release of Ca2 from the sarcoplasmic reticulum (SR)
•resulting rise in intracellular Ca2+
•concentration activates the troponin complex
•initiating the contraction of the muscle. 43
![Page 44: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/44.jpg)
Cardiac Muscle (CIC)
• In cardiac muscle the mechanism
• of E-C coupling involve Ca2+ induced Ca2+release(CICR).
• The cardiac DHPR serves as a functional voltage-dependent Ca2+ channel allowing entry of extracellular Ca2+which raises the local intracellular Ca2+concentration
44
![Page 45: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/45.jpg)
Calcium Induced Calcium Release (CICR)
1. Ca++ enters the cell through L-type calcium channels
2. Ca++ stimulates Ca++ release from the SR via RyR
3. Ca++ interacts with contractile proteins to initiate shortening of the myocyte
Intracellular [Ca] 10-7 to 10-5 M
1 2
3
45
![Page 46: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/46.jpg)
Cardiac Muscle (CIC)
• Release of Ca2+ from the SR is controlled by the Ca2+ release
channel or RYR.
• The RYR1 and RYR2 are homotetramers
• with a subunit molecular mass of ~565 kDa, and they share 66% sequence identity and ~80% overall homology 46
![Page 47: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/47.jpg)
• Approximately 4/5 of the RYRs are predicted to be cytoplasmic, with
• only 1/5 of the molecule at the carboxy terminus forming the
• luminal and membrane-spanning domains
47
![Page 48: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/48.jpg)
CALIUM CHANNEL BLOCKERS
THREE CLASSIFICATIONS:
PHENYLAKYLAMINES
1,4-DIHYDROPYRIDINES
BENZOTHIAZEPINES
48
![Page 49: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/49.jpg)
Ca+2 Channel Blockers • The Three classifications differ in their Tissue
Selectivity,
• Their Binding Site, location with the Alph 1 Subunit,
• Their mechanisms of calcium blockade
• 1,4 dihydopyrimidines are selective for the arteriolar beds
• The phenylalkylamines and benzothiazepines are selective for the AV node 49
![Page 50: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/50.jpg)
CALCIUM CHANNEL BLOCKERS
• BLOCK Ca+2 entry into
• Cardiac and vascular smooth muscle at
• The Alpha-1 subunit of the L-type voltage gated Ca+2 ion Channel (slow channels)
• Reduce myocardial O2 demand by decreasing cardiac afterload and augments o2 supply by increasing blood flow (coronaryvasodilatation)
50
![Page 51: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/51.jpg)
CALCIUM CHANNEL BLOCKERS
• Decreased myocardial contractility• Decreased heart rate –decrease O2
demand (verapamil+diltiazam)• Decreased activity of SA node• Decreased rate of conduction of
cardiac impulses through the SA node
• Vascular smooth muscle relaxation with associated vasodilatation and decreases in systemic blood pressure
51
![Page 52: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/52.jpg)
PHENYLALKYLAMINE• Verapamil—primary site is the AV node,
used for angina, essential hypertension
• May be useful in maternal and fetal tachydysrhythmias as well as premature labor, however
• It may decrease uterine placental blood flow, use caution
• Negative inotrope and chronotrope effects may be enhanced with in beta antagonist 52
![Page 53: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/53.jpg)
• Used with caution with left ventricular dysfunction, conduction abnormalities or bradydysrhythmias, diltiazem better tolerated
• Isoproterenol useful to increase hr in drug induced heart block
53
![Page 54: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/54.jpg)
1,4-DIHYDROPYRIMIDINES• Nifedipine—greater coronary and
peripheral arterial vasodilator properties than verapamil
• The peripheral vasodilatation decreases systemic blood pressure, this activates the baroreceptors , increasing heart rate
• SL nifedipine has serious adverse side effects; cerebrovascular ischemia, myocardial ischemia, severe hypotension—no longer used hypertensive emergencies
54
![Page 55: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/55.jpg)
NICARDIPINE
• Lacks affects on SA and AV node
• Has the Greatest vasodilating effects of all the calcium channel blockers, vasodilatation prominent in the coronary arteries
• Used for acute hypertension
55
![Page 56: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/56.jpg)
• Nicardipine-lacks affects on the SA and AV node, Minimal cardiac depressant effects
• Greatest Coronary Arterial Vasodilatation –no coronary steal
• Used in combination with Beta Blockers for Angina
• 1,4-Dihydropyrimidines produce the greatest dilatation of the peripheral arterioles
56
![Page 57: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/57.jpg)
1,4-DIHYDROPYRIMIDINES
• Nicardipine-
• Available oral or IV route. Oral 1/3 life is 72 hrs.
• Metabolized by the liver and is 95% protein bound
57
![Page 58: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/58.jpg)
1,4-DIHYDROPYRIMIDINES
• Oral Cardene Dose Equivalent
I.V. Infusion Rate
20 mg q8h 0.5 mg/hr
30 mg q8h 1.2 mg/hr
40 mg q8h 2.2 mg/hr
58
![Page 59: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/59.jpg)
NICARDIPINE
• Dose not cause significant increase in ICP
• CPP=MAP-ICP
• PRECISE CONTROL OF B/P WILL MAINTAIN CPP
59
![Page 60: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/60.jpg)
60
![Page 61: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/61.jpg)
NICARDIPINE
• Can be used as a tocolytic, with fewer side effects, however pulmonary edema has been reported
• Used to blunt the hemodynamic effects of ECT
61
![Page 62: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/62.jpg)
NICARDIPINE
• Common side effects include; headache (14.6%), N/V (4.9%) and tachycardia (3.5%)
• Use caution with a patient in CHF (Congestive Heart Failure) and is being treated with a betablocker, advanced aortic stenosis, significant left ventricular dysfunction, portal hypertension, impaired renal and hepatic function.
62
![Page 63: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/63.jpg)
NICARDIPINE
• 25mg/10cc
• Must be diluted
• 25mg in 240cc = 0.1mg/cc
• Premixed 20mg/200cc = 0.1mg/cc
Initiate 5mg/hr (50cc/hr)
• Do not exceed 15mg/hr (150cc/hr)
63
![Page 64: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/64.jpg)
1,4--DIHYDROPYRIMIDINES
• Nimodipine—vasodilating cerebral arteries preventing or attenuating cerebral vasospasm that accompanies sub-arachnoid hemorrhage
• Cerebral protection after global ischemia as associated with cardiac arrest 64
![Page 65: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/65.jpg)
BENOTHIAZEPINES-Diltazem
Blocks predominantly the calcium channels of the av node
Used for svt and essential
Hypertention
Minimal cardiodepressant effects unlikely to interact with beta-adrenergic drugs
65
![Page 66: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/66.jpg)
LOCAL ANESTHETIC
• VERAPIMIL HAS A POTENT LOCAL ANESTHETIC ACTIVITY
• WHICH MAY INCREASE THE RISK OF LOCAL ANESTHETIC TOXICITY
• WHEN REGIONAL ANESTHESIA IS ADMINISTERED TO PATIENTS BEING TREATED WITH THIS DRUG
66
![Page 67: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/67.jpg)
ANESTHETICS AND CA++ BLOCKERS
• BOTH ARE VASODILATORS MYOCARDIAL DEPRESSANTS
• POTENTIATE BOTH DEPOLARIZNG AND NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND THE CIRCULATORY EFFECTS OF THE VOLATILE AGENTS
• THERE IS NO EVIDENCE THAT PATIENTS BEING TREATED CHRONICALLY WITH CA++ BLOCKERS ARE AT INCREASED RISK FOR ANESTHESIA
67
![Page 68: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/68.jpg)
DANTROLENE
• DANTROLENE AND VERAPAMIL OR (DILTIAZEM) CONCURRENTLY, RESULTS IN EXTREME HYPERKALEMIA—NEED HEMODYNAMIC MONITORING
68
![Page 69: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/69.jpg)
CALCIUM CHANNEL BLOCKERS
• MAY INTERFER WITH PLATELET FUNCTION
• MAY INCREASE PLASMA CONCENTRATION OF DIGOXIN; DECREASING PLASMA CLEARANCE
69
![Page 70: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/70.jpg)
CALCIUM CHANNEL BLOCKERS
• RISK OF CHRONIC TREATMENT
• INCREASED BLEEDING WITH DIHYDROPYRIMIDINE DERVATIVES
• INCREASE RISK OF CANCER
70
![Page 71: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/71.jpg)
Cardiac Muscle (CIC)
• In cardiac muscle the mechanism
of E-C coupling involve Ca2+ induced Ca2+ release(CICR).
• The cardiac DHPR serves as a functional voltage-dependent Ca2+ channel allowing entry of extracellular Ca2+which raises the local intracellular Ca2+concentration.
71
![Page 72: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/72.jpg)
Proteins Bound to DHPR or RYR
• In addition to (mechanical gating or CICR),
• Ca2+ release is likely to be modulated by other proteins bound to the DHPR or to RYR.
• One of these protein is Calmodulin
72
![Page 73: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/73.jpg)
Mutation
Timothy syndrome is a multi-system disease e.g. cognitive abnormalities, immune deficiency, hypoglycemia, as the result of mutations of CaV1.2.
73
![Page 74: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/74.jpg)
The mutation of glycine to arginine: converts a neighboring serine to a consensus site for phosphorylation by calmodulin kinase.
The phosphorylation of this site promotes a slow gating mode of the calcium channel, increasing Ca2+ entry and resulting in cytotoxicity.
74
![Page 75: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/75.jpg)
Class IV drugs
• The Ca2+ channel is the target for the interaction with class IV antiarrhythmic drugs.
• Phenylalkylamine, verapamil and the benzothiazepine, diltiazem.
75
![Page 76: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/76.jpg)
K-ION CHANNEL
• Crucial Regulator Membrane excitability
• CNS
• HEART
• Tissue
• Smooth muscle
• White blood cells76
![Page 77: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/77.jpg)
77
Drugs acting on potassium Channels
Potassium Channel Blockers
Anti-arrhythmic Hypoglycemic
•Sotalol
•Bretylium
•Amiodarone
Difetilide, Ibutilide
Not selective to K
Highly selective to K
•Sulfonyl-Urea Agents
•Non-Sulfonyl-Urea Agents
•Repaglinide
![Page 78: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/78.jpg)
Antiarrythmic IV -LIKE
• K channel opener (hyperpolarization)
• Repolarization: Unchanged
• Example: Adenosine
78
![Page 79: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/79.jpg)
79
![Page 80: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/80.jpg)
Transmembrane segments (S4) senses voltage shifts in the Membrane Opens the ion channel
KV family EAG family KCNQ family
80
![Page 81: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/81.jpg)
• Each family contain a number of members:• They are known as subfamily• Each of this is the product of different gene• KV1.5 most important sub-family member in
the human heart• This channel makes the ultra rapidly
activating• Delayed in the mammalian atrium.
81
![Page 82: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/82.jpg)
CHLORIDE CHANNELLigan Gated
Benzodiazepine
82
![Page 83: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/83.jpg)
83
![Page 84: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/84.jpg)
The GABA-A Receptor ?• Major mammalian inhibitory neurotransmitter receptor
• Pentameric integral membrane protein containing an ion channel selective for chloride ions.
Extracellular part
Transmembrane part
![Page 85: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/85.jpg)
Neuroreceptors• Activation causes a net change in the electrical
properties (membrane potential) of that neuron and determines its activity.
• Increase in Chloride ions = HYPERPOLARIZATION
• Neurons less likely to fire.
• Calming, tranquilizing, prevents us being overwhelmed by stressful situations!
85
![Page 86: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/86.jpg)
Benzodiazepine Binding Site• Allosterically stimulate the function of the
GABA-A receptor.
86
![Page 87: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/87.jpg)
Allosteric stimulation • Binds at its own separate site away from the
active site.
87
![Page 88: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/88.jpg)
GABAA receptor• Benzodiazepine receptors associated
with GABA chloride channel complex
• GABA agonists cause opening of the Cl channel.
• benzodiazepine receptor is a modulating unit, modifying the response to GABA.
88
![Page 89: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/89.jpg)
Ligand-gated ion channel neuroreceptors
Cell membrane
neurotransmitterNT
Channel closed
Cl-
Cl-
Cl-
Cl-
Cl-
Cl-Cl-
89
![Page 90: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/90.jpg)
Ligand-gated ion channel neuroreceptors
NT
pore Cl-
Cl-
Cl-
Cl-
Cl-
Cl-
Cl-
Cl-
Cl-Cl-
Cl-Cl-
Cl-
Cl-
Cl-
Cl-
Cl-
Cl-Cl-
90
![Page 91: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/91.jpg)
Ligand-gated ion channel neuroreceptors
NT
91
![Page 92: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/92.jpg)
Ligand-gated ion channel neuroreceptors
NT
92
![Page 93: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/93.jpg)
93
![Page 94: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/94.jpg)
94
![Page 95: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/95.jpg)
95
![Page 96: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/96.jpg)
96
![Page 97: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/97.jpg)
97
![Page 98: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/98.jpg)
98
![Page 99: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/99.jpg)
Na+ Channel Modulation
• Phosphorylation • sodium channel function is modulated by serine/threonine
and tyrosine kinases as well as tyrosine phosphatases (Yu et al, Science 1997)
• Mutation – altered amino acid sequence/structure can change the biophysical properties of the Na+ channel
• Pharmacology – block Na+ channel to reduce the conductance
• Proteolysis- (cleavage) Proteases may cleave specific residues or sequences that inactivate a channel, or significantly alter the biophysical properties
99
![Page 100: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/100.jpg)
Why Na+ Channels/Modulation Are Important
• Neuronal depolarization, Action Potential• Neuronal Excitability• Cardiac Excitability• Muscle Excitability• The basis of neuronal/cardiac/muscular function
relies on the propagation of action potentials, down axons, sarcolemma, myocardium, as well as requiring synaptic transmission.
• Differential excitability alters the electrical conduction/transmission properties of the “circuit”
100
![Page 101: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/101.jpg)
Na + Channel Blockers/Pharmacological Agents
• Tetrodotoxin (TTX)
• Amioderone (Antiarrhythmic)
• Lidocaine (Anesthetic agents)
• Procainamide (Anesthetic agents)
• Mexilitine (Antiarrhythmic)
• Ketamine (General Anesthetic agents)
• Many, many others101
![Page 102: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/102.jpg)
Some Na+ Channels Outside The Nervous System
• Naf – “Funny Current” in pacemaker cells of the heart (SA node/ectopic pacemakers)
• SA node –Beta 1 receptor
(sympathetic receptor)
• Nav in the myocardium, sarcolemma, and T-tubules and motor endplate
102
![Page 103: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/103.jpg)
Na+ Channel Activation
• Change in transmembrane potential results in a conformation change in the Na+ channel
• The four S4 segment alpha helices translocate, thus leading to the opening of the channel pore
• The energy of the conformational change in the channel during activation is mediated by the reduction in overall entropy of the system.
• The voltage sensor is a highly charged sequence of amino acids that “aligns” itself according to the electrical field present
• A change in transmembrane potential creates unfavorable electrodynamic interaction for the voltage sensor, hence a conformational shift lowers the energy of the system and creates more favorable conditions
103
![Page 104: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/104.jpg)
Patch Clamping/Transfection
Transfection 1. Kv1.3 cDNA in Plasmid2. Lipofectamine complexing3. Add to Dishes4. Patch 28-48 hrs after
104
![Page 105: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/105.jpg)
Transition: A General Overview of Articles Before Discussion
• From Basic structure/function relationships to a gating mechanism
• The gating of a bacterial Na+ channel and application of Na+ channel activation and biophysical properties
• Article 1 – A gating hinge in Na+ channels: a molecular switch for electrical signaling
105
![Page 106: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/106.jpg)
Proposed conformational shift of A-helix caused by substitution of Proline for G219Prolines in alpha helices after the first turn (4th residue) cause a kink in the helix.This kink is caused by proline being unable to complete the H-bonding chain of the helix and steric or rotamer effects that keep proline from adapting the prefered helical geometry
Conserved glycineIn the S6 domain
106
![Page 107: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/107.jpg)
Na+ Channel Gating
• Current theory holds that a change in transmembrane potential “flips” the conformation of the voltage sensor, thereby opening the channel pore
• A mutation, G219P, glycine 219 changed to proline alters the conformation of the S6 domain
• The mutant channel now favors a state much like the “open” state of a wild-type channel
• NOTE: these bacterial Na+ channels are homotetramers of identical subunits
107
![Page 108: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/108.jpg)
Regulation and Modulation in Na Channels
• Phosphorylation effects• Mutations in ball-and-
chain affect inactivation speed
• Cleavage of any part of Na channel protein
• Drugs can be used as modulators
• NO modulates Na currents (Ribeiro et al., 2007)– NO donors reduce
peak Na current
• ENaC modulated by accessory proteins (Gormley et al., 2003)
108
![Page 109: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/109.jpg)
• Pharmacology – block Na+ channel to reduce the conductance
• Proteolysis- (cleavage) Proteases may cleave specific residues or sequences that inactivate a channel, or significantly alter the biophysical properties
Na+ Channel Modulation
109
![Page 110: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/110.jpg)
Na+ Channel Modulation• Phosphorylation • sodium channel function is modulated
by serine/threonine and tyrosine kinases as well as tyrosine phosphatases (Yu et al, Science 1997)
• Mutation – altered amino acid sequence/structure can change the biophysical properties of the Na+ channel
110
![Page 111: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/111.jpg)
Sodium Channels - Function
• Play a central role in the transmission of action potentials along a nerve
• Can be in different functional states (3) -A resting state when it can respond to a
depolarizing voltage changes -Activated, when it allows flow of Na+ ions through the -Inactivated, when subjected to a “suprathreshold” potential, the channel will not open (hyperpolarization)
111
![Page 112: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/112.jpg)
Pharmacology (i.e. drugs of choice)
• Saxitoxin (STX), from red tide, used to count Na channels (Ritchie et al. 1976)
• Tetrodotoxin (TTX), from fugu puffer fish, local anesthetics also block Na channel flux– Local anesthetic: #
channels open at once Saxitoxin
www.chemfinder.com112
![Page 113: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/113.jpg)
• Single linked protein makes up ion channel– P-loop reflects speed
of inactivation , subunits modify
channel function but are not essential to create the pore
• Ligand-gated channels do not have voltage sensor, but ligand binding site
• Voltage gated channels have voltage sensor on S4 in each domain– Speculation: domain
sensors have special functions (Kuhn and Greef, 1999)
113
![Page 114: CALCIUM CHANNEL BLOCKERS 1PHRM-520-L.S.No-7th-E-01](https://reader035.vdocuments.us/reader035/viewer/2022081511/56649d945503460f94a7c1a1/html5/thumbnails/114.jpg)
• Drugs bind to receptors– Can be used to count receptors, block channels
(ex: identify which current is responsible for some spiking)
• Na channel is not perfectly selective– Also permeable to K+ ions, though much less
than Na+ (Chandler and Meves, 1965)– Therefore, drug application may not necessarily
block one ion completely• Drug responses are variable
– Cardiac cells respond less to TTX than skeletal muscle cells (Ritchie and Rogart, 1977; Cohen et al., 1981)
114